Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic MSCs for Bone Regeneration in Periodontal Disease
NCT05975892Phase 2Unknown
- Sponsor
- Instituto Venezolano de Investigaciones Científicas
- Start
- Aug 2018
- Primary completion
- Aug 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic bone marrow mesenchymal stromal cells (IVIC) in periodontal disease, sponsored by Instituto Venezolano de Investigaciones Científicas. Primary endpoints: Clinical Attachment Level at 12 months, Probing Pocket Depth at 12 months and 4 more. Status: unknown.
02
Drugs
allogeneic bone marrow mesenchymal stromal cells (IVIC)
03
Conditions
periodontal disease
Beyond the preview
Go deeper on NCT05975892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05975892.